Language selection

Search

Patent 2118207 Summary

Third-party information liability

Some of the information on this Web page has been provided by external sources. The Government of Canada is not responsible for the accuracy, reliability or currency of the information supplied by external sources. Users wishing to rely upon this information should consult directly with the source of the information. Content provided by external sources is not subject to official languages, privacy and accessibility requirements.

Claims and Abstract availability

Any discrepancies in the text and image of the Claims and Abstract are due to differing posting times. Text of the Claims and Abstract are posted:

  • At the time the application is open to public inspection;
  • At the time of issue of the patent (grant).
(12) Patent: (11) CA 2118207
(54) English Title: BACILLUS THURINGIENSIS M200 FOR THE BIOLOGICAL CONTROL OF AGRICULTURAL AND HORTICULTURAL ENTOMOLOGICAL PESTS
(54) French Title: BACILLUS THURINGIENSIS M200 DESTINE A LA LUTTE BIOLOGIQUE CONTRE LES INSECTES NUISIBLES EN AGRICULTURE ET EN HORTICULTURE
Status: Term Expired - Post Grant Beyond Limit
Bibliographic Data
(51) International Patent Classification (IPC):
  • C12N 1/20 (2006.01)
  • A1N 37/18 (2006.01)
  • C7K 14/32 (2006.01)
  • C7K 14/325 (2006.01)
(72) Inventors :
  • MEADOWS, MARTIN P. (United Kingdom)
  • ELLIS, DEBORAH J. (United Kingdom)
  • JARRETT, PAUL (United Kingdom)
(73) Owners :
  • THE MICROBIO GROUP LIMITED
(71) Applicants :
  • THE MICROBIO GROUP LIMITED (United Kingdom)
(74) Agent: SMART & BIGGAR LP
(74) Associate agent:
(45) Issued: 1998-09-22
(22) Filed Date: 1994-10-14
(41) Open to Public Inspection: 1996-04-15
Examination requested: 1995-01-17
Availability of licence: N/A
Dedicated to the Public: N/A
(25) Language of filing: English

Patent Cooperation Treaty (PCT): No

(30) Application Priority Data: None

Abstracts

English Abstract


The invention relates to a strain of Bacillus
thuringiensis M200, a sample of which has been deposited under
the accession number NCIMB 40385, or a recombinant or mutant
thereof having entomocidal activity against lepidopterous
pests. The invention also relates to the use of the strain,
recombinant or mutant in control of insect pests.


French Abstract

L'invention a trait à une souche de Bacillus thuringiensis M200, dont un échantillon a été déposé sous le numéro d'entrée NCIMB 40485, ou une souche recombinante ou mutante de ce bacille ayant une activité insecticide contre les espèces de lépidoptères nuisibles. L'invention a également trait à l'usage de la souche ou de la souche recombinante ou mutante dans la lutte contre les insectes nuisibles.

Claims

Note: Claims are shown in the official language in which they were submitted.


THE EMBODIMENTS OF THE INVENTION IN WHICH AN EXCLUSIVE
PROPERTY OR PRIVILEGE IS CLAIMED ARE DEFINED AS FOLLOWS:
1. A strain of Bacillus thuringiensis M200, a sample of
which has been deposited under the accession number NCIMB
40385, or a recombinant or mutant thereof having entomocidal
activity against lepidopterous pests.
2. An entomocidal substance derived from Bacillus
thuringiensis strain M200 (NCIMB 40385), or from a recombinant
or mutant thereof, the entomocidal substance being a
spore-crystal complex.
3. The use of Bacillus thuringiensis strain M200 (NCIMB
40385), or a recombinant or mutant thereof, for control of
insect pests susceptible to M200 including insect pests
selected from the group consisting of Plutella xylostella,
Pieris rapae, Pieris brassicae and Trichoplusia ni.
4. An entomocidal composition comprising Bacillus
thuringiensis strain M200 (NCIMB 40385), or a recombinant or
mutant thereof, or an entomocidal substance according to
claim 2, together with a carrier, diluent, surfactant or
application-promoting adjuvant.
5. An entomocidal composition according to claim 4 in
the form of a wettable powder comprising from 25 to 75% by
weight of Bacillus thuringiensis M200, or a recombinant or
- 18 -

mutant thereof, or an entomocial substance derivable from
Bacillus thuringiensis strain M200 (NCIMB 40385), or from a
recombinant or mutant thereof, said entomocidal substance
being a spore-crystal complex, from 0 to 5% by weight of
sodium lignosulfate, from 0 to 5% by weight of sodium
laurylsulfate, from 0 to 10% by weight of sodium
diisobutylnapthalene sulfonate, from 0 to 2% by weight of
octylphenol polyethylene glycol ether (7-8 moles of ethylene
oxide), from 5 to 10% by weight of highly dispersed silicic
acid; and from 0 to 62% by weight of kaolin.
- 18a -

6. A composition according to claim 4, also containing a further biologically active
compound selected from fertilisers, micronutrient donors, plant growth preparations,
herbicides, insecticides, fungicides, bactericides, nematicides and molluscicides and
mixtures thereof.
7. A composition according to claim 4, comprising from 0.1 to 99% by weight of Bacillus
thuringiensis M200 or a recombinant or mutant thereof, or an entomocidal substance
according to claim 2, from 1 to 99% by weight of a solid or liquid adjuvant; and from 0 to
25% by weight of a surfactant.
8. A method of combatting lepidopterous pests which comprises applying to the pests or to
their environment an entomocidally effective amount of Bacillus thuringiensis strain M200
(NCIMB 40385), or a recombinant or mutant thereof, or an entomocidal substance
according to claim 2, or a composition containing said strain, recombinant, mutant or
substance.
- 19-

Description

Note: Descriptions are shown in the official language in which they were submitted.


CA 02ll8207 l998-04-06
BIOLOGICAL CONTROL OF PESTS
This invention relates to biological methods of pest
control and more particularly to methods and compositions
utilising Bacillus thuringiensis for the control of
agricultural and horticultural pests.
Bacillus thuringiensis is a spore forming bacterium
which has long been known to kill insects and many hundreds of
isolates (strains) of this species have been listed. The
properties of individual B. thuringiensis strains and their
activity against insect pests vary widely from strain to
strain.
We have now isolated a new strain of Bacillus
thuringiensis which has been found to be highly active against
agricultural and horticultural pests including those of the
family Pieridae, including Pieris brassicae (Large White
Butterfly), and pests of the family Yponomeutidae, including
Plutella xylostella (Diamond-back moth). The activity of the
new strain, designated M200, is several-fold greater towards
the above pests than many known strains of B. thuringiensis
including those used commercially and those under current
development which have been described in the literature.
The present invention comprises Bacillus
thuringiensis strain M200 a sample of which has been deposited
under the Budapest Treaty with the National Collection of
Industrial and Marine Bacteria under Accession No. NCIMB
40385, on 20 March 1991.
The present invention also comprises the use of B.
thuringiensis strain M200 for the control of pests which
21489-9160

CA 02118207 1998-04-06
affect plants. Accordingly the invention comprises a method
of pest control in which agricultural and horticultural
produce are protected against pests by application of this new
strain to the growing plants or other horticultural products
or to their growing locations. The invention also comprises
compositions containing the new strain and formulated for
agricultural or
la
21489-9160

2118207
horticultural app' ~rticln. The invention is applicable also to variants, mutants and recombinants
of the new strain which are similarly biologically effective.
A recombinant of strain M200 is one which is produced when the strain has been used as a
recipient for additional genetic material in the form of an additional plasmid. For example, the
additional plasmid can be transferred by plasmid transfer (conjugation) from another Bt strain,
or the additional plasmid can contain eg a cloned toxin gene prepared by recombinant DNA
techniques and inserted into the recipient strain by transformation using techniques well known
to those skilled in the art. In both cases, the recipient strain retains its original genetic material
and thus the same insecticidal activity of the original strain is maintained. Of course, additional
or enhanced insecticidal activity may be present in the recombinant strain by virtue of the added
genetic material.
The invention will now be further described.
The strain Bacillus thuringiensis M200 has the H-serotype 3a3b. When grown for 24h at 30~C
on nutrient agar the colonies are circular, entire, convex, off-white, have a ground glass
appearance and a diameter of 2-8mm. The vegetative cells are Gram-positive aerobic rods
producing sub-terminal spores towards the end of the growth cycle. At the same time as
sporulation, a parasporal, proteinaceous crystal is produced which is approximately the same
size as the spore.

2 ~ 7
biochemical profile of M200 on standard substrates (API ZONE test strip) is shown below.
HD1 is a commercially available strain.
Strain Code No.
Reaction
M200 HD1
NO3 (nitrate reduction) +
TRP (indole production)
GLU (glucose acidification)
ADH (arginine dihydrolase) +
URE (urease)
ESC (esculin hydrolysis) +
GEL (gelatine hydrolysis) + +
PNPG (,~-glactosidase)
GLU (glucose assimilation) + +
ARA (arabinose assimilation)
MNE (mannose assimilation)
MAN (mannitol assimilation)
NAG (N-acetyl glucosamine assimilation) + +
MAL(maltose assimilation) + +
GNT (gluconate assimilation) + +
CAP (caprate assimilation)
ADI (adipate assimilation)
MLT (malate assimilation) + +
CIT (citrate assimilation)
PAC (phenylacetate assimilation)
* Trade - ma rk
21489-9160
B

2118~07
B. thuringiensis strains produce a number of proteins which are toxic to insects. There is an
internationally recognised classification for these toxins. By the use of specific DNA probes it
is possible to determine which toxin genes a particular strain possesses. The major toxin gene
content of strains HD1 and M200 is compared below.
HD1: CRY 1A(a), CRY 1A(b), CRY 1A(c), CRYIIA
M200: CRY 1A(a), CRY 1 A(b) [not expressed], CRY 1A(c), CRY 1 E(c), CRYIIA
B. thuringiensis can be produced on a large scale by submerged fermentation using processes
such as those described by Lee et al in Microbial Biomass [1979, A.H. Rose (ed). Academic
Press pp 91-114]. Typical growth media may contain any of the following ingredients in various
combinations: fishmeal, cottonseed meal, soybean meal, molasses, diammonium phosphate,
starch. During production by fermentation, after normal growth of Bacillus thuringiensis, the
mother cells Iyse and release the spores and crystals into the growth medium. The spores and
crystals may be harvested by centrifugation or filtration, spray drying, vacuum drying, or a
method of precipitation, such as the lactose coprecipitation technique as reported by Dulmage
etal(Joumal of Invertebrate Pathology, 15, 15-20, 1970). The resulting spore-crystal complex
is stable for long periods and can be formulated into a product suitable for application to crops.
The invention also includes the use of delta endotoxins derived from the above-mentioned new
organism. The invention provides an entomocidal substance derived from Bacillus thuringiensis
strain M200, or from a recombinant or mutant thereof. In one embodiment the entomocidal
substance is a spore-crystal complex. The spore-crystal complex or the composition containing
it may be administered to the plants or crops to be protected together with certain other
insecticides or chemicals without loss or potency.

2118207
It is possible to kill the spores in the spore-crystal (eg by gamma irradiation), or to avoid
producing spores by use of an asporogenous crystaliferous mutant, thereby producing a non-
viable product. A non-viable product may be advantageous in certain circumstances where it is
desired to prevent the spread of bacteria for aesthetic reasons or to avoid causing disease in
beneficial insects. However, non-viable products are generally not as active as those containing
live spores and as a further disadvantage there is the increased cost of killing the spores.
The invention further provides an entomocidal substance derived from Bacillus thuringiensis
strain M200 (NCIMB 40385) or a recombinant or mutant thereof, or an entomocidal substance
as defined above together with an agricultural adjuvant such as a carrier, diluent, surfactant or
application-promoting adjuvant. The composition may also contain a further biologically active
compound selected from fertilisers, micronutrient donors, plant growth preparations, herbicides,
insecticides, fungicides, bactericides, nematicides and molluscicides and mixtures thereof. The
composition may comprise from 0.1 to 99% by weight of Bacillus thuringiensis M200 or the
recombinant or mutant thereof, or the entomocidal substance; from 1 to 99.9% by weight of a
solid or liquid adjuvant and from 0 to 25% by weight of a surfactant.
The invention in addition provides a method of combatting pests which comprises applying to the
pests or to their environment an entomocidally effective amount of Bacillus thuringiensis strain
M200, or a I~COl 1 Ib-. ,ant or mutant thereof, or an entomocidal substance as defined above, or a
composition containing said strain, recombinant, mutant or substance.
Bacillus thuringiensis strain M200 or the compositions containing it may be administered to the
plants or crops to be protected together with certain other insecticides or chemicals without loss
of potency. It is compatible with most other commonly used agricultural spray materials but
should not be used in extremely alkaline spray solutions. It may be administered as a dust, a

~118207
suspension, a wettable powder or in any other material form suitable for agricultural application.
The invention furthermore relates to a method of treating crops which comprises applying an
entomocidally effective amount of B. thuringiensis M200, or a composition thereof.
Bacillus thuringiensis M200, is normally applied in the form of compositions and can be applied
to the crop area to be treated, simultaneously or in succession, with further biologically active
compounds. These compounds may be both fertilisers or micronutrient donors or other
preparations that influence plant growth. They may also be selective herbicides, insecticides,
fungicides, bactericides, nemAticides, ~ uscicWes or mixtures of several of these preparations,
if desired, together with further carriers, surfactants or application-promoting adjuvants
customarily employed in the art of formulation. Suitable carriers and adjuvants can be solid or
liquid and correspond to the substances ordinarily employed in formulation technology, eg natural
or regenerated mineral substances, solvents, dispersants, wetting agents, takifiers, binders or
fertilisers.
The fommulations, ie the compositions, preparations or mixtures containing B. thuringiensis M200
as an active ingredient or combinations thereof with other active ingredients, and, where
appropriate, a solid or liquid adjuvant, are prepared in known manner eg by homogeneously
mixing and/or grinding the active ingredients with extenders eg solvents, solid carriers and in
some cases surface-acting compounds (surfactants).
Suitable solvents are: aromatic hydrocarbons, preferably the fractions containing 8 to 12 carbon
atoms, eg xylene mixtures or substituted napthalenes, phthalates such as dibutylphthalate or
dioctylphthalate, aliphatic hydrocarbons such as cyclohexane or paraffins, alcohols and glycols,
such as cyclohexanone, strongly polar solvents such as N-methyl-2-pyrrolidone,

~118207
dimethylsufoxide or dimethylformamide as well as vegetable oils or epoxidised vegetable oils
such as epoxidised coconut oil or soybean oil; or water.
The solid carriers used eg for dusts and dispersable powders, are normally natural mineral fillers
such as calcite, talcum, kaolin, montmorillonite or attapulgite. In order to improve the physical
properties it is also possible to add highly dispersed silicic acid or highly dispersed absorbent
polymers. Suitable granulated adsorptive carriers are porous types, for example pumice, broken
brick, sepiolite or bentonite; and suitable nonsorbent carriers are materials such as calcite or
sand. In addition, a great number of pregranulated materials of inorganic or organic nature can
be used, eg especially dolomite or pulverised plant residues.
Depending on the nature of the active ingredients to be formulated, suitable surface-active
compounds are non-ionic, cationic and/or anionic surfactants having good emulsifying, dispersing
and wetting properties. The term "surfactants" will also be understood as comprising mixtures
of surfactants.
Suitable anionic surfactants can be both water-soluble soaps and water-soluble synthetic
surface-acting compounds. Suitable soaps are the alkali metal salts, alkaline earth metal salts
or unsubstituted or substituted ammonium salts of higher fatty acids (C10-C22), eg the sodium or
potassium salts of oleic or stearic acid, or of natural fatty acid mixtures which can be obtained,
eg from coconut oil or tallow oil. Further suitable surfactants are also the fatty acid methyltaurin
salts as well as modified and unmodified phospholipids. More frequently, however, so-called
surfactants are used, especially fatty sulfonates, fatty sulfates, sulfonated benzimidazole
derivatives or alkylaryl-sulfonates.

2II8207
The fatty sulfonates or sulfates are usually in the forms of alkali metal salts, alkaline earth metal
salts or unsubstituted or substituted a,~ ,on -lrn salts and generally contain a C8-C22 alkyl radical
which also includes the alkyl moiety of acyl radicals, eg the sodium or calcium salt of
lignosulfonic acid, or dodecylsufate, or of a mixture of fatty alcohol sulfates obtained from natural
fatty acids. These compounds also comprise the salts of sulfuric acid esters and sulfonic acids
of fatty alcohol/ethylene oxide adducts. The sulfonated benzimidazole derivatives preferably
contain 2 sulfonic acid groups and one fatty acid radical containing about 8 to 22 carbon atoms.
Examples of alkyl-arylsufonates are the sodium, calcium or triethanolamine salts of
dodecylbenzenesulfonic acid, dibutylnapththalenesulfonic acid or of a naphthalenesulfonic
acid/fo",~ldehyde condensation product. Also suitable are corresponding phosphates, eg salts
of the phosphoric acid ester of an adduct of p-nonylphenol with 4 to 14 moles of ethylene oxide.
Non-ionic surfactants are preferably polyglycol ether derivatives of aliphatic or cycloaliphatic
alcohols or saturated or unsaturated fatty acids and alkylphenols, said derivatives containing 3
to 30 glycol ether groups and 8 to 20 carbon atoms in the (aliphatic) hydrocarbon moiety and 6
to 18 carbon atoms in the alkyl moiety of the alkylphenols.
Further suitable non-ionic surfactants are the water-soluble adducts of polyethylene oxide with
polypropylene glycol, ethylenediaminopolypropylene glycol and alkylpolypropylene glycol
containing 1 to 10 carbon atoms in the alkyl chain, which adducts contain 20 to 250 ethylene
glycol ether groups and 10 to 100 propylene glycol ether groups. These compounds usually
contain 1 to 5 ethylene glycol units per propylene glycol unit.
Representative examples of non-ionic surfactants are nonylphenolpolyethoxyethanols, castor oil
polyglycol ethers, polypropylene/polyethylene oxide adducts, tributylphenoxypolyethoxyethanol,
polyethylene glycol and octylphenoxypolyethoxyethanol. Fatty acid esters of polyoxyethylene

2118207
sorbitan, such as polyoxyethylene sorbitan-trioleate, are also suitable non-ionic surfactants.
Cationic surfactants are preferably quaternary ammonium salts which contain, as N-substituent,
at least one C8-Cz alkyl radical and, as further substituents, lower unsubstituted or halogenated
alkyl, benzyl or hydroxyl-lower alkyl radicals. The salts are preferably in the form of halides,
methylsulfates or ethylsulfates eg stearyltrimethylammonium chloride or benzyldi-(2-
chloroethyl)ethylammonium bromide.
The surfactants customarily employed in the art of formulation are described eg in "McCutcheon's
Detergents and Emulsifiers Annual", MC Publishing Corp, Ridgewood, New Jersey, 1979; Dr
Helmut Stache, "Tensid Taschenbuch" (Handbook of Surfactants), Carl Hanser Verlag,
MunichNienna.
The entomocidal compositions usually contain 0.1 to 99%, preferably 0.1 to 95% of Bacillus
thuringiensis M200, or combination thereof with other active ingredients, 1 to 99.9% of a solid
or liquid adjuvant and 0 to 25%, preferably 0.1 to 20%, of a surfactant.
Whereas commercial products are preferably formulated as concentrates, the end user will
normally employ dilute formulations of substantially lower concentration.
The compositions may also contain further ingredients, such as stabilisers, antifoams, viscosity
regulators, binders, tackifiers as well as fertilisers or other active ingredients in order to obtain
special effects.
The invention will now be further described with reference to experimental and field test data
obtained in comparative testing of isolate M200 and of other B. thuringiensis isolates.

~118207
FY~nple 1 - Large Scale Culture of B. thuringiensis
Bacillus thuringiensis strain M200 can be cultured on a large scale as follows:
The strain is maintained in Iyophilized ampoules, which are used as stocks for inoculating the
strain onto agar slopes. The slopes are incubated for 1 to 5 days at 20 to 40~C, preferably 25
to 33~C, following which they are used to inoculate shaken flasks containing an aqueous culture
medium. Typical growth media might contain the following ingredients in various combinations:
3-5% fishmeal, 2-3% cottonseed meal, 2-3% soybean meal, 2-4% molasses, 1% diammonium
phosphate and 0.5-1% starch. The flasks are shaken at a temperature of 20 to 40~C preferably
30~C for 1 to 5, preferably 1 to 2 days (this vegetative growth stage can be repeated optionally
at least once in a separate flask), and used to inoculate a preculture fermenter containing an
aqueous cultivating medium. The fermentation medium containing the inoculate is stirred and
aerated at a temperature of 20 to 40~C, preferably 30 to 35~C, (optionally this preculture
fermentation stage can be repeated at least once in a separate larger container), before being
introduced at 2 to 20 per cent by weight of the incubating liquor into a production fermenter,
containing an aqueous cultivating medium. The medium is stirred and aerated at a temperature
of 20 to 40~C, preferably 30 to 35~C until the Bacillus thuringiensis M200 broth is harvested when
sporulation and crystal production in the production fermenter reaches a maximum. The agar
and broth used for preparation of inocula for the preculture fermenter should contain at least one
nitrogen source, at least one carbon source and at least one salt, preferably peptone, glucose
and at least one salt. The fermentation media should contain at least one nitrogen source (eg
peptone, yeast extract, corn steep liquor, soya bean meal, cotton seed meal, fishmeal), at least
one carbohydrate source (eg glucose, lactose, sucrose, starch or raw material rich in these
constituents) at at least one mineral salt. The nitrogen and carbohydrate should be balanced to
- 10-

2118207
exhaust as near as possible simultaneously. Cultures can be concentrated after harvesting by
centrifugation to produce a slurry containing a spore/crystal concentrate. The concentrate can
be converted into a dry powder by spray-drying.
Example 2 - Insect Bioassays
The activity of B. thuringiensis strain M200 against the insects Pieris brassicae and Plutella
xylostella was compared in bioassays with the commercially available strain HD1. Bacterial
powders were prepared as described in Example 1 and activities against insects assayed by the
addition of a series of concentrations of the powders to artificial diets on which the larvae fed.
For P. brassicae the semi-synthetic diet of David, W.A.L. and Gardiner, R.O.C. (1965), [Nature,
London 207, No 4999, pp 882-883] was used. All larvae used in bioassays were neonates.
Mortality was recorded after 5 days with the temperature maintained at 25~C. For P. xylostella
the same semi-synthetic diet was used, except that all antibiotics were omitted, but all larvae
used in bioassays were at the beginning of the third instar. Mortality was recorded after 5 days
with the temperature maintained at 25~C.
It can be seen from the results expressed in Table 1 that the activity of B. thuringiensis strain
M200 towards P. brassicae is 2.5 to 4-fold greater than that of HD1. Similarly the activity of B.
thuringiensis strain M200 towards P. xylostella is 1 6-fold greater than that of HD1.

- ~118207
Example 3 - Formulation exa"--ples for solid active ingredients of Bacillus thurin~iensis
M200 or cG~IlJinations thereof with other active ingredients
(throughout, percentages are by weight)
1. Wettable powders
a) b) c)
Bacillus thuringiensisM200 25% 50% 75%
sodiumlignosulfonate 5% 5%
sodium laurylsulfate 3% - 5%
sodium diisobutylnapthalenesulfonate - 6% 10%
octylphenol polyethylene glycol ether
(7-8 moles of ethylene oxide) - 2%
highly dispersed silicic acid 5% 10% 10%
kaolin 62% 27%
Bacillus thunngiensis M200, is thoroughly mixed with the adjuvants and the mixture is thoroughly
ground in a suitable mill, affording wettable powders which can be diluted with water to give
suspensions of the desired concentration.
- 12-

2118207
2. Fmulsifiable concentrate
Bacillus thuringiensis M200 10%
octylphenol polyethylene glycol ether (4-5 moles of ethylene oxide) 3%
calcium dodecylbenzenesulfonate 3%
castor oil polyglycol ether (36 moles of ethylene oxide) 4%
cyclohexanone 30%
xylene mixture 50%
Emulsions of any required concentration can be obtained from this concentrate by dilution with
water.
3. Dusts
a) b)
Bacillus thuringiensisM200 5% 8%
talcum 95%
kaolin - 92%
Ready for use dusts are obtained by mixing the active ingredient with the carriers and grinding
the mixture in a suitable mill.
- 13-

2I18~7
4. Extruder Qranulate
Bacillus thuringiensis M200 10%
sodium lignosulfonate 2%
carboxymethylcellulose 1 %
kaolin 87%
The active ingredient or combination is mixed and ground with the adjuvants and the mixture is
subsequently moistened with water. The mixture is extruded, granulated and then dried in a
stream of air.
5. Coated granule
Bacillus thuringiensis M200 3%
polyethylene glycol (mol. wt. 200) 3%
kaolin 94%
The finely ground active ingredient or combination is uniformly applied in a mixer to the kaolin
moistened with polyethylene glycol. Non-dusty coated granulates are obtained in this manner.
- 14-

2t.I8207
6. Suspension Concentrate
Bacillus thuringiensis M200 40%
ethylene glycol 10%
nonylphenol polyethylene glycol ether (15 moles of ethylene oxide) 6%
sodium lignosulfonate 10%
carboxymethylcellulose 1 %
37% aqueous formaldehyde solution 0.2%
silicone oil in the form of a 75% aqueous emulsion 0.8%
water 32%
The finely ground active ingredient or combination is intimately mixed with the adjuvants giving
a suspension concer,l,ale from which suspensions of any desired concentration can be obtained
by dilution with water.
Example 4 - Field Trials
Bacillus thuringiensis strain M200 was prepared as a wettable powder formulation using the
method described in Example 3. This fommulation contained 25% by weight of strain M200. The
strain was tested for control of P. xylostella, Pieris rapae and Trichoplusia ni in a series of field
trials on cabbages. The results, expressed as percentage control of insect larvae, are
summarised in Table 2. These results clearly indicate that, in the field, strain M200 is highly
active against the insect pests tested. The wettable powder used in these trials represents only
one example of an effective formulation, preparation of many other effective formulations will be
known to those skilled in the art.

~1 18207
Table 1
Activity of Bacillus thurinyiensis M200 against Pieris brassicae and Plutella xylostella
LC50 of Isolate
Isolate
(Fiducial limits)
P. bra-ssie~e
M200 0.16 (0.07 - 0.26)
M200 (replicate) 0.096 (0.038 - 0.17)
HD1 0.40 (0.30 - 0.50)
P. xylostella
M200 0.07 (0.014 - 0.50)
HD1 1 .32 (0.95 -1 .83)
LC50 is expressed as the dose of B. thuringiensis powder (~g per g diet) which gave 50%
mortality.
- 16-

21 18207
Table 2
Activity of B. thuri"giensis strain M200 in field trials against Plutella xylostella, Pieris
rapae and Trichoplusia nion caL,~age
Application Rate % Control
Strain
(Ib/acre) P. xylostella T. ni P. rapae
0.25 84.3 - 100.0
0.50 93.9 - 97.0
M200'
1.00 95.0 83.5 100.0
1.50 - 93 7
Wettable powder containing 25% B. thuringiensis strain M200 and prepared as described in
Example 3.

Representative Drawing

Sorry, the representative drawing for patent document number 2118207 was not found.

Administrative Status

2024-08-01:As part of the Next Generation Patents (NGP) transition, the Canadian Patents Database (CPD) now contains a more detailed Event History, which replicates the Event Log of our new back-office solution.

Please note that "Inactive:" events refers to events no longer in use in our new back-office solution.

For a clearer understanding of the status of the application/patent presented on this page, the site Disclaimer , as well as the definitions for Patent , Event History , Maintenance Fee  and Payment History  should be consulted.

Event History

Description Date
Inactive: IPC expired 2020-01-01
Inactive: IPC expired 2020-01-01
Inactive: Expired (new Act pat) 2014-10-14
Letter Sent 2012-10-09
Inactive: Single transfer 2012-09-12
Inactive: IPC from MCD 2006-03-11
Grant by Issuance 1998-09-22
Inactive: Final fee received 1998-04-06
Inactive: Received pages at allowance 1998-04-06
Pre-grant 1998-04-06
Notice of Allowance is Issued 1997-10-07
Notice of Allowance is Issued 1997-10-07
4 1997-10-07
Letter Sent 1997-10-07
Inactive: Status info is complete as of Log entry date 1997-10-02
Inactive: Application prosecuted on TS as of Log entry date 1997-10-02
Inactive: IPC assigned 1997-08-08
Inactive: Approved for allowance (AFA) 1997-08-08
Inactive: IPC assigned 1997-08-08
Inactive: First IPC assigned 1997-08-08
Inactive: IPC removed 1997-08-08
Inactive: IPC removed 1997-08-08
Inactive: IPC assigned 1997-08-08
Inactive: IPC removed 1997-08-08
Inactive: IPC removed 1997-08-08
Inactive: IPC assigned 1997-08-08
Inactive: IPC removed 1997-08-08
Inactive: IPC assigned 1997-08-08
Inactive: IPC removed 1997-08-08
Inactive: IPC removed 1997-08-08
Application Published (Open to Public Inspection) 1996-04-15
All Requirements for Examination Determined Compliant 1995-01-17
Request for Examination Requirements Determined Compliant 1995-01-17

Abandonment History

There is no abandonment history.

Maintenance Fee

The last payment was received on 1998-08-28

Note : If the full payment has not been received on or before the date indicated, a further fee may be required which may be one of the following

  • the reinstatement fee;
  • the late payment fee; or
  • additional fee to reverse deemed expiry.

Patent fees are adjusted on the 1st of January every year. The amounts above are the current amounts if received by December 31 of the current year.
Please refer to the CIPO Patent Fees web page to see all current fee amounts.

Owners on Record

Note: Records showing the ownership history in alphabetical order.

Current Owners on Record
THE MICROBIO GROUP LIMITED
Past Owners on Record
DEBORAH J. ELLIS
MARTIN P. MEADOWS
PAUL JARRETT
Past Owners that do not appear in the "Owners on Record" listing will appear in other documentation within the application.
Documents

To view selected files, please enter reCAPTCHA code :



To view images, click a link in the Document Description column (Temporarily unavailable). To download the documents, select one or more checkboxes in the first column and then click the "Download Selected in PDF format (Zip Archive)" or the "Download Selected as Single PDF" button.

List of published and non-published patent-specific documents on the CPD .

If you have any difficulty accessing content, you can call the Client Service Centre at 1-866-997-1936 or send them an e-mail at CIPO Client Service Centre.

({010=All Documents, 020=As Filed, 030=As Open to Public Inspection, 040=At Issuance, 050=Examination, 060=Incoming Correspondence, 070=Miscellaneous, 080=Outgoing Correspondence, 090=Payment})


Document
Description 
Date
(yyyy-mm-dd) 
Number of pages   Size of Image (KB) 
Description 1997-06-17 17 537
Abstract 1997-06-17 1 14
Claims 1997-06-17 3 73
Abstract 1998-04-05 1 11
Description 1998-04-05 18 543
Description 1996-04-14 17 529
Abstract 1996-04-14 1 11
Claims 1996-04-14 2 52
Commissioner's Notice - Application Found Allowable 1997-10-06 1 164
Courtesy - Certificate of registration (related document(s)) 2012-10-08 1 102
Correspondence 1998-04-05 4 107
Correspondence 1997-10-06 1 101
Fees 1996-09-02 1 78
Prosecution correspondence 1995-01-16 1 41
Prosecution correspondence 1997-02-23 4 158
Examiner Requisition 1996-08-22 2 119
Prosecution correspondence 1995-07-11 2 57
Courtesy - Office Letter 1994-12-05 2 82
Courtesy - Office Letter 1995-05-08 1 29
PCT Correspondence 1996-03-05 2 75
Courtesy - Office Letter 1996-03-14 1 18
Courtesy - Office Letter 1996-03-14 1 15